BB&T Securities’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

BB&T Securities’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,893	Closed	-$215K	–	1656
2018 Q4	$215K	Sell	5,893 -400	-6%	-$17.1K	﹤0.01%	1331
2018 Q3	$305K	Hold	6,293	–	–	﹤0.01%	1316
2018 Q2	$270K	Sell	6,293 -6,657	-51%	-$280K	﹤0.01%	1327
2018 Q1	$542K	Buy	12,950 +155	+1%	+$6.75K	0.01%	986
2017 Q4	$556K	Hold	12,795	–	–	0.01%	960
2017 Q3	$544K	Buy	12,795 +150	+1%	+$6.36K	0.01%	956
2017 Q2	$544K	Buy	12,645 +1,232	+11%	+$51.9K	0.01%	943
2017 Q1	$477K	Buy	+11,413	New	+$465K	0.01%	902

Other funds holding XPH

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

BB&T Securities's XPH Position: Q1 2019 in Review

BB&T Securities sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2019, closing a stake of 5,893 shares — an estimated $215K sold.

BB&T Securities first reported a position in XPH in Q1 2017 and held it in 8 quarters. The position peaked at $556K in Q4 2017. 80 funds tracked by Wall St. Rank hold XPH as of Q1 2019.

BB&T Securities reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2019 after selling out during the quarter.
BB&T Securities sold 5,893 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2019, an estimated $215K.
BB&T Securities first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2017 and held it in 8 quarters.
BB&T Securities's State Street SPDR S&P Pharmaceuticals ETF position peaked at $556K in Q4 2017.
80 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2019.

Based on BB&T Securities's 13F filing for Q1 2019, filed 14 May 2019.